Deciphering the mechanism of action of VP343, an antileishmanial drug candidate, in Leishmania infantum

Summary: Antileishmanial chemotherapy is currently limited due to severe toxic side effects and drug resistance. Hence, new antileishmanial compounds based on alternative approaches, mainly to avoid the emergence of drug resistance, are needed. The present work aims to decipher the mechanism of acti...

Deskribapen osoa

Xehetasun bibliografikoak
Egile Nagusiak: Sameh Obeid, Eloisa Berbel-Manaia, Valérie Nicolas, Indira Dennemont, Julien Barbier, Jean-Christophe Cintrat, Daniel Gillet, Philippe M. Loiseau, Sébastien Pomel
Formatua: Artikulua
Hizkuntza:English
Argitaratua: Elsevier 2023-11-01
Saila:iScience
Gaiak:
Sarrera elektronikoa:http://www.sciencedirect.com/science/article/pii/S2589004223022216

Antzeko izenburuak